25 XP   0   0   10

Beigene Ltd
Buy, Hold or Sell?

Let's analyse Beigene together

PenkeI guess you are interested in Beigene Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Beigene Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Beigene Ltd

I send you an email if I find something interesting about Beigene Ltd.

Quick analysis of Beigene (30 sec.)










What can you expect buying and holding a share of Beigene? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
11.1%

What is your share worth?

Current worth
HK$20.38
Expected worth in 1 year
HK$15.44
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
HK$-4.94
Return On Investment
-6.2%

For what price can you sell your share?

Current Price per Share
HK$79.20
Expected price per share
HK$73.80 - HK$94.30
How sure are you?
50%

1. Valuation of Beigene (5 min.)




Live pricePrice per Share (EOD)

HK$79.20

Intrinsic Value Per Share

HK$-68.82 - HK$-78.32

Total Value Per Share

HK$-48.44 - HK$-57.94

2. Growth of Beigene (5 min.)




Is Beigene growing?

Current yearPrevious yearGrowGrow %
How rich?$3.5b$5b-$1.2b-32.6%

How much money is Beigene making?

Current yearPrevious yearGrowGrow %
Making money-$220.4m-$502.1m$281.7m127.8%
Net Profit Margin-43.1%-142.5%--

How much money comes from the company's main activities?

3. Financial Health of Beigene (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#23 / 1016

Most Revenue
#27 / 1016

Most Profit
#1008 / 1016

Most Efficient
#534 / 1016

What can you expect buying and holding a share of Beigene? (5 min.)

Welcome investor! Beigene's management wants to use your money to grow the business. In return you get a share of Beigene.

What can you expect buying and holding a share of Beigene?

First you should know what it really means to hold a share of Beigene. And how you can make/lose money.

Speculation

The Price per Share of Beigene is HK$79.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Beigene.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Beigene, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$20.38. Based on the TTM, the Book Value Change Per Share is HK$-1.23 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-2.85 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Beigene.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.27-0.3%-0.17-0.2%-0.37-0.5%-0.27-0.3%-0.17-0.2%
Usd Book Value Change Per Share-0.18-0.2%-0.16-0.2%-0.36-0.5%0.060.1%0.070.1%
Usd Dividend Per Share0.000.0%0.000.0%0.060.1%0.020.0%0.010.0%
Usd Total Gains Per Share-0.18-0.2%-0.16-0.2%-0.30-0.4%0.080.1%0.080.1%
Usd Price Per Share14.06-14.51-13.89-16.14-9.63-
Price to Earnings Ratio-13.00--4.64--9.67--5.56--4.24-
Price-to-Total Gains Ratio-78.32-106.90--54.34--14.32--14.66-
Price to Book Ratio5.40-5.18-3.75-6.62-4.12-
Price-to-Total Gains Ratio-78.32-106.90--54.34--14.32--14.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.11384
Number of shares98
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share-0.160.06
Usd Total Gains Per Share-0.160.08
Gains per Quarter (98 shares)-15.447.52
Gains per Year (98 shares)-61.7730.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-62-7272320
20-124-134134750
30-185-196207080
40-247-2582793110
50-309-32034117140
60-371-38240140170
70-432-44447163200
80-494-50654187230
90-556-56860210260
100-618-63067234290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%2.018.00.010.0%3.033.00.08.3%3.033.00.08.3%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%12.024.00.033.3%12.024.00.033.3%
Dividend per Share0.00.04.00.0%4.00.08.033.3%4.00.016.020.0%4.00.032.011.1%4.00.032.011.1%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%12.024.00.033.3%12.024.00.033.3%

Fundamentals of Beigene

About Beigene Ltd

BeiGene, Ltd., through its subsidiaries, engages in the development and commercialization of oncology medicines worldwide. Its products include BRUKINSA to treat various blood cancers; TEVIMBRA to treat various solid tumor and blood cancers; PARTRUVIX for the treatment of various solid tumor malignancies; XGEVA to treat bone metastases from solid tumors and multiple myeloma, as well as giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; POBEVCY to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC); BAITUOWEI, to treat breast and prostate cancers; TAFINLAR and MEKINIST to treat NSCLC and melanoma; VOTRIENT for advance renal cell carcinoma; AFINITOR for advance renal cell carcinoma, NET, SEGA, & breast cancers; and ZYKADIA to treat ALK + NSCLC. The company is also developing inhibitors comprising Sonrotoclax (BGB-11417), BGB-10188, BGB-21447, Ociperlimab (BGB-A1217), Surzebiclimab (BGB-A425), BGB-15025, BGB-26808, Lifirafenib (BGB-283), BGB-3245, BGB-30813, and BGB-43395; antibodies, including Zanidatamab, BGB-A445, and BGB-A3055, as well as BGB-16673, a BTK-targeted CDAC, and BGB-24714, a SMAC mimetic. It has collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, Bristol Myers Squibb company, Shandong Luye Pharmaceutical Co., Ltd., Nanjing Leads Biolabs, Inc., EUSA Pharma, Assembly Biosciences, Inc., Bio-Thera Solutions, Ltd., and Nanjing Leads Biolabs Co., Ltd. The company was incorporated in 2010 and is based in Grand Cayman, the Cayman Islands.

Fundamental data was last updated by Penke on 2024-04-18 16:08:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Beigene Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Beigene earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Beigene to the Biotechnology industry mean.
  • A Net Profit Margin of -57.9% means that $-0.58 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Beigene Ltd:

  • The MRQ is -57.9%. The company is making a huge loss. -2
  • The TTM is -43.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-57.9%TTM-43.1%-14.9%
TTM-43.1%YOY-142.5%+99.4%
TTM-43.1%5Y-261.0%+217.9%
5Y-261.0%10Y-520.0%+259.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-57.9%-197.2%+139.3%
TTM-43.1%-210.4%+167.3%
YOY-142.5%-279.3%+136.8%
5Y-261.0%-436.8%+175.8%
10Y-520.0%-599.3%+79.3%
1.1.2. Return on Assets

Shows how efficient Beigene is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Beigene to the Biotechnology industry mean.
  • -6.3% Return on Assets means that Beigene generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Beigene Ltd:

  • The MRQ is -6.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-3.7%-2.6%
TTM-3.7%YOY-7.1%+3.4%
TTM-3.7%5Y-7.6%+3.8%
5Y-7.6%10Y-8.2%+0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%-13.6%+7.3%
TTM-3.7%-12.9%+9.2%
YOY-7.1%-11.9%+4.8%
5Y-7.6%-14.2%+6.6%
10Y-8.2%-16.2%+8.0%
1.1.3. Return on Equity

Shows how efficient Beigene is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Beigene to the Biotechnology industry mean.
  • -10.4% Return on Equity means Beigene generated $-0.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Beigene Ltd:

  • The MRQ is -10.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.4%TTM-5.8%-4.6%
TTM-5.8%YOY-10.1%+4.3%
TTM-5.8%5Y-11.3%+5.5%
5Y-11.3%10Y-6.3%-5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.4%-17.0%+6.6%
TTM-5.8%-16.1%+10.3%
YOY-10.1%-15.4%+5.3%
5Y-11.3%-20.0%+8.7%
10Y-6.3%-21.1%+14.8%

1.2. Operating Efficiency of Beigene Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Beigene is operating .

  • Measures how much profit Beigene makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Beigene to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Beigene Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-13.4%+13.4%
TTM-13.4%YOY-127.5%+114.1%
TTM-13.4%5Y-257.8%+244.4%
5Y-257.8%10Y-524.2%+266.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM-13.4%-224.4%+211.0%
YOY-127.5%-288.4%+160.9%
5Y-257.8%-475.2%+217.4%
10Y-524.2%-624.7%+100.5%
1.2.2. Operating Ratio

Measures how efficient Beigene is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.77 means that the operating costs are $1.77 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Beigene Ltd:

  • The MRQ is 1.772. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.694. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.772TTM1.694+0.078
TTM1.694YOY3.347-1.653
TTM1.6945Y4.273-2.579
5Y4.27310Y6.517-2.245
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7722.997-1.225
TTM1.6943.247-1.553
YOY3.3473.766-0.419
5Y4.2735.675-1.402
10Y6.5177.857-1.340

1.3. Liquidity of Beigene Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Beigene is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.32 means the company has $2.32 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Beigene Ltd:

  • The MRQ is 2.322. The company is able to pay all its short-term debts. +1
  • The TTM is 3.091. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.322TTM3.091-0.769
TTM3.091YOY4.301-1.211
TTM3.0915Y4.790-1.699
5Y4.79010Y6.285-1.496
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3223.930-1.608
TTM3.0914.251-1.160
YOY4.3015.436-1.135
5Y4.7906.045-1.255
10Y6.2856.363-0.078
1.3.2. Quick Ratio

Measures if Beigene is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Beigene to the Biotechnology industry mean.
  • A Quick Ratio of 0.20 means the company can pay off $0.20 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Beigene Ltd:

  • The MRQ is 0.199. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.719. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.199TTM1.719-1.520
TTM1.719YOY4.789-3.070
TTM1.7195Y5.958-4.239
5Y5.95810Y5.476+0.482
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1993.629-3.430
TTM1.7194.065-2.346
YOY4.7895.397-0.608
5Y5.9585.993-0.035
10Y5.4766.277-0.801

1.4. Solvency of Beigene Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Beigene assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Beigene to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.39 means that Beigene assets are financed with 39.1% credit (debt) and the remaining percentage (100% - 39.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Beigene Ltd:

  • The MRQ is 0.391. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.337. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.391TTM0.337+0.054
TTM0.337YOY0.292+0.045
TTM0.3375Y0.312+0.025
5Y0.31210Y0.284+0.028
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3910.332+0.059
TTM0.3370.334+0.003
YOY0.2920.268+0.024
5Y0.3120.366-0.054
10Y0.2840.390-0.106
1.4.2. Debt to Equity Ratio

Measures if Beigene is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Beigene to the Biotechnology industry mean.
  • A Debt to Equity ratio of 64.1% means that company has $0.64 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Beigene Ltd:

  • The MRQ is 0.641. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.513. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.641TTM0.513+0.129
TTM0.513YOY0.414+0.099
TTM0.5135Y0.460+0.052
5Y0.46010Y0.256+0.204
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6410.381+0.260
TTM0.5130.390+0.123
YOY0.4140.334+0.080
5Y0.4600.434+0.026
10Y0.2560.466-0.210

2. Market Valuation of Beigene Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Beigene generates.

  • Above 15 is considered overpriced but always compare Beigene to the Biotechnology industry mean.
  • A PE ratio of -13.00 means the investor is paying $-13.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Beigene Ltd:

  • The EOD is -9.352. Based on the earnings, the company is expensive. -2
  • The MRQ is -13.001. Based on the earnings, the company is expensive. -2
  • The TTM is -4.644. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.352MRQ-13.001+3.649
MRQ-13.001TTM-4.644-8.357
TTM-4.644YOY-9.665+5.021
TTM-4.6445Y-5.562+0.918
5Y-5.56210Y-4.237-1.325
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.352-2.315-7.037
MRQ-13.001-2.560-10.441
TTM-4.644-2.664-1.980
YOY-9.665-4.122-5.543
5Y-5.562-6.258+0.696
10Y-4.237-6.108+1.871
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Beigene Ltd:

  • The EOD is -8.847. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.298. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.417. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.847MRQ-12.298+3.451
MRQ-12.298TTM-12.417+0.119
TTM-12.417YOY-10.315-2.102
TTM-12.4175Y-7.653-4.764
5Y-7.65310Y-5.311-2.342
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.847-3.067-5.780
MRQ-12.298-3.251-9.047
TTM-12.417-3.545-8.872
YOY-10.315-5.595-4.720
5Y-7.653-8.315+0.662
10Y-5.311-8.708+3.397
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Beigene is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.40 means the investor is paying $5.40 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Beigene Ltd:

  • The EOD is 3.887. Based on the equity, the company is fair priced.
  • The MRQ is 5.403. Based on the equity, the company is overpriced. -1
  • The TTM is 5.182. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.887MRQ5.403-1.516
MRQ5.403TTM5.182+0.221
TTM5.182YOY3.750+1.432
TTM5.1825Y6.624-1.442
5Y6.62410Y4.124+2.500
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.8871.905+1.982
MRQ5.4032.111+3.292
TTM5.1822.095+3.087
YOY3.7502.836+0.914
5Y6.6243.443+3.181
10Y4.1243.794+0.330
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Beigene Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.406-1.234-12%-2.852+103%0.467-401%0.566-348%
Book Value Per Share--20.37621.916-7%29.437-31%21.546-5%13.661+49%
Current Ratio--2.3223.091-25%4.301-46%4.790-52%6.285-63%
Debt To Asset Ratio--0.3910.337+16%0.292+34%0.312+25%0.284+38%
Debt To Equity Ratio--0.6410.513+25%0.414+55%0.460+39%0.256+151%
Dividend Per Share----0%0.502-100%0.134-100%0.075-100%
Eps---2.117-1.307-38%-2.914+38%-2.079-2%-1.319-38%
Free Cash Flow Per Share---2.238-2.518+12%-2.856+28%-2.332+4%-1.452-35%
Free Cash Flow To Equity Per Share---0.239-1.654+592%-2.883+1106%0.576-142%0.635-138%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---78.316--------
Intrinsic Value_10Y_min---68.815--------
Intrinsic Value_1Y_max---10.096--------
Intrinsic Value_1Y_min---9.919--------
Intrinsic Value_3Y_max---28.622--------
Intrinsic Value_3Y_min---27.360--------
Intrinsic Value_5Y_max---45.082--------
Intrinsic Value_5Y_min---41.991--------
Market Cap98470949068.800-52%149682405962.400154850381490.200-3%146389224626.200+2%162779199789.710-8%96953411774.372+54%
Net Profit Margin---0.579-0.431-26%-1.425+146%-2.610+350%-5.200+798%
Operating Margin----0.1340%-1.2750%-2.5780%-5.2420%
Operating Ratio--1.7721.694+5%3.347-47%4.273-59%6.517-73%
Pb Ratio3.887-39%5.4035.182+4%3.750+44%6.624-18%4.124+31%
Pe Ratio-9.352+28%-13.001-4.644-64%-9.665-26%-5.562-57%-4.237-67%
Price Per Share79.200-39%110.100113.625-3%108.738+1%126.368-13%75.449+46%
Price To Free Cash Flow Ratio-8.847+28%-12.298-12.417+1%-10.315-16%-7.653-38%-5.311-57%
Price To Total Gains Ratio-56.343+28%-78.325106.902-173%-54.344-31%-14.319-82%-14.660-81%
Quick Ratio--0.1991.719-88%4.789-96%5.958-97%5.476-96%
Return On Assets---0.063-0.037-41%-0.071+12%-0.076+19%-0.082+30%
Return On Equity---0.104-0.058-44%-0.101-3%-0.113+8%-0.063-40%
Total Gains Per Share---1.406-1.234-12%-2.349+67%0.601-334%0.641-319%
Usd Book Value--3537483491.3463814275236.072-7%5056866205.864-30%3585121498.759-1%2260183236.083+57%
Usd Book Value Change Per Share---0.180-0.158-12%-0.364+103%0.060-401%0.072-348%
Usd Book Value Per Share--2.6022.799-7%3.759-31%2.751-5%1.744+49%
Usd Dividend Per Share----0%0.064-100%0.017-100%0.010-100%
Usd Eps---0.270-0.167-38%-0.372+38%-0.265-2%-0.168-38%
Usd Free Cash Flow---388566189.408-438447896.077+13%-491451240.841+26%-387736202.6910%-240318131.204-38%
Usd Free Cash Flow Per Share---0.286-0.322+12%-0.365+28%-0.298+4%-0.185-35%
Usd Free Cash Flow To Equity Per Share---0.031-0.211+592%-0.368+1106%0.074-142%0.081-138%
Usd Market Cap12574740196.086-52%19114443241.39919774393716.299-3%18693903984.766+2%20786903813.146-8%12380950683.587+54%
Usd Price Per Share10.114-39%14.06014.510-3%13.886+1%16.137-13%9.635+46%
Usd Profit---367569260.545-220436751.690-40%-502175715.271+37%-342475650.453-7%-216285734.724-41%
Usd Revenue--634437066.254614721944.096+3%353995910.086+79%289416253.209+119%173189994.920+266%
Usd Total Gains Per Share---0.180-0.158-12%-0.300+67%0.077-334%0.082-319%
 EOD+3 -5MRQTTM+8 -24YOY+21 -135Y+11 -2310Y+12 -22

3.2. Fundamental Score

Let's check the fundamental score of Beigene Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.352
Price to Book Ratio (EOD)Between0-13.887
Net Profit Margin (MRQ)Greater than0-0.579
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.199
Current Ratio (MRQ)Greater than12.322
Debt to Asset Ratio (MRQ)Less than10.391
Debt to Equity Ratio (MRQ)Less than10.641
Return on Equity (MRQ)Greater than0.15-0.104
Return on Assets (MRQ)Greater than0.05-0.063
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Beigene Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.051
Ma 20Greater thanMa 5091.175
Ma 50Greater thanMa 10093.477
Ma 100Greater thanMa 20099.106
OpenGreater thanClose79.950
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets5,805,275
Total Liabilities2,267,948
Total Stockholder Equity3,537,327
 As reported
Total Liabilities 2,267,948
Total Stockholder Equity+ 3,537,327
Total Assets = 5,805,275

Assets

Total Assets5,805,275
Total Current Assets4,203,414
Long-term Assets1,601,861
Total Current Assets
Cash And Cash Equivalents 3,171,800
Short-term Investments 2,600
Net Receivables 358,027
Inventory 416,122
Total Current Assets  (as reported)4,203,414
Total Current Assets  (calculated)3,948,549
+/- 254,865
Long-term Assets
Property Plant Equipment 1,389,910
Long Term Investments 89,644
Intangible Assets 108,855
Long-term Assets Other 10,906
Long-term Assets  (as reported)1,601,861
Long-term Assets  (calculated)1,599,315
+/- 2,546

Liabilities & Shareholders' Equity

Total Current Liabilities1,810,113
Long-term Liabilities457,835
Total Stockholder Equity3,537,327
Total Current Liabilities
Short Long Term Debt 688,366
Accounts payable 315,111
Other Current Liabilities 68,004
Total Current Liabilities  (as reported)1,810,113
Total Current Liabilities  (calculated)1,071,481
+/- 738,632
Long-term Liabilities
Long term Debt 197,618
Capital Lease Obligations Min Short Term Debt44,201
Long-term Liabilities Other 170,846
Long-term Liabilities  (as reported)457,835
Long-term Liabilities  (calculated)412,665
+/- 45,170
Total Stockholder Equity
Total Stockholder Equity (as reported)3,537,327
Total Stockholder Equity (calculated)0
+/- 3,537,327
Other
Capital Stock135
Common Stock Shares Outstanding 1,359,513
Net Invested Capital 4,423,311
Net Working Capital 2,393,301
Property Plant and Equipment Gross 1,639,122



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-12-31
> Total Assets 
53,621
136,965
135,608
116,764
265,228
251,230
235,425
405,813
376,729
473,975
1,049,059
1,046,479
1,708,927
1,653,856
2,408,627
2,249,684
2,172,232
2,150,318
1,881,070
1,612,289
4,067,212
3,903,290
5,566,390
5,600,757
5,821,004
5,524,116
5,286,334
8,645,949
8,021,388
7,378,207
6,726,013
6,379,290
5,956,775
5,728,736
5,524,879
5,805,275
5,805,2755,524,8795,728,7365,956,7756,379,2906,726,0137,378,2078,021,3888,645,9495,286,3345,524,1165,821,0045,600,7575,566,3903,903,2904,067,2121,612,2891,881,0702,150,3182,172,2322,249,6842,408,6271,653,8561,708,9271,046,4791,049,059473,975376,729405,813235,425251,230265,228116,764135,608136,96553,621
   > Total Current Assets 
47,188
130,200
128,211
106,269
251,782
232,754
209,953
374,399
336,178
418,691
962,330
913,497
1,585,702
1,516,707
2,180,195
1,943,842
1,796,730
1,755,680
1,435,550
1,172,696
3,595,187
3,392,404
4,965,736
4,960,690
5,140,979
4,799,039
4,432,835
7,613,880
6,948,139
6,345,876
5,749,168
5,207,078
4,704,318
4,401,419
4,053,542
4,203,414
4,203,4144,053,5424,401,4194,704,3185,207,0785,749,1686,345,8766,948,1397,613,8804,432,8354,799,0395,140,9794,960,6904,965,7363,392,4043,595,1871,172,6961,435,5501,755,6801,796,7301,943,8422,180,1951,516,7071,585,702913,497962,330418,691336,178374,399209,953232,754251,782106,269128,211130,20047,188
       Cash And Cash Equivalents 
13,898
25,156
27,450
17,869
208,506
58,084
85,532
87,514
97,750
261,006
208,510
239,602
490,634
438,420
643,485
712,937
764,492
918,948
856,151
618,011
1,957,101
1,345,014
1,464,470
1,381,950
1,901,819
1,776,448
1,383,310
4,375,678
4,347,162
4,531,137
4,197,132
3,869,564
3,538,644
3,410,368
3,067,336
3,171,800
3,171,8003,067,3363,410,3683,538,6443,869,5644,197,1324,531,1374,347,1624,375,6781,383,3101,776,4481,901,8191,381,9501,464,4701,345,0141,957,101618,011856,151918,948764,492712,937643,485438,420490,634239,602208,510261,00697,75087,51485,53258,084208,50617,86927,45025,15613,898
       Short-term Investments 
30,497
101,509
93,894
82,617
38,720
168,535
118,086
280,660
229,726
146,424
548,925
597,914
973,381
931,208
1,390,276
1,068,509
849,167
618,803
375,768
364,728
1,417,097
1,807,744
3,254,300
3,268,725
2,910,472
2,605,452
2,533,617
2,241,962
1,897,783
1,172,554
871,998
665,251
294,057
105,693
106,989
2,600
2,600106,989105,693294,057665,251871,9981,172,5541,897,7832,241,9622,533,6172,605,4522,910,4723,268,7253,254,3001,807,7441,417,097364,728375,768618,803849,1671,068,5091,390,276931,208973,381597,914548,925146,424229,726280,660118,086168,53538,72082,61793,894101,50930,497
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
181,471
29,428
49,970
47,664
45,041
52,764
67,670
61,478
57,636
72,810
77,975
82,690
87,657
79,673
103,928
118,456
163,563
500,175
216,348
192,279
202,645
198,984
309,628
338,140
309,079
358,027
358,027309,079338,140309,628198,984202,645192,279216,348500,175163,563118,456103,92879,67387,65782,69077,97572,81057,63661,47867,67052,76445,04147,66449,97029,428181,4710000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,366
25,738
23,700
79,096
89,024
88,674
83,681
83,314
87,790
95,634
91,624
114,627
110,199
101,316
96,635
106,331
42,532
130,488
23,944
0
023,944130,48842,532106,33196,635101,316110,199114,62791,62495,63487,79083,31483,68188,67489,02479,09623,70025,73826,3660000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
375,502
394,638
445,520
439,593
472,025
510,886
600,654
640,067
680,025
725,077
853,499
1,032,069
1,073,249
1,032,331
976,845
1,172,212
1,252,457
1,327,317
1,471,337
1,601,861
1,601,8611,471,3371,327,3171,252,4571,172,212976,8451,032,3311,073,2491,032,069853,499725,077680,025640,067600,654510,886472,025439,593445,520394,638375,5020000000000000000
       Property Plant Equipment 
5,931
6,234
6,541
6,612
7,702
9,752
16,554
25,977
30,723
33,770
55,322
62,568
76,990
90,510
111,262
157,061
270,430
287,312
301,838
324,922
331,840
348,726
379,907
448,267
460,895
491,147
551,373
705,036
740,170
750,683
829,881
845,946
1,053,558
1,144,500
1,289,123
1,389,910
1,389,9101,289,1231,144,5001,053,558845,946829,881750,683740,170705,036551,373491,147460,895448,267379,907348,726331,840324,922301,838287,312270,430157,061111,26290,51076,99062,56855,32233,77030,72325,97716,5549,7527,7026,6126,5416,2345,931
       Goodwill 
0
0
0
0
0
0
0
0
0
0
1,984
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
109
0
0
001091091091091091091091091091091091091091091091091091091091091091091091,9840000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,964
26,241
36,756
49,344
55,711
53,951
87,428
100,792
83,890
87,587
96,080
91,779
97,947
95,607
89,281
89,644
89,64489,28195,60797,94791,77996,08087,58783,890100,79287,42853,95155,71149,34436,75626,24111,96400000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
19,688
19,715
19,925
19,007
18,928
52,230
6,841
6,509
6,178
5,846
5,563
5,375
5,188
53,731
4,813
12,008
14,104
46,679
45,807
43,325
40,849
40,616
39,735
46,895
53,657
108,855
108,85553,65746,89539,73540,61640,84943,32545,80746,67914,10412,0084,81353,7315,1885,3755,5635,8466,1786,5096,84152,23018,92819,00719,92519,71519,6880000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,122
100,708
137,395
108,716
122,549
130,435
178,694
137,347
158,497
167,862
200,485
179,453
203,273
150,627
47,553
83,802
80,273
53,346
0
0
0053,34680,27383,80247,553150,627203,273179,453200,485167,862158,497137,347178,694130,435122,549108,716137,395100,70898,1220000000000000000
> Total Liabilities 
27,853
27,052
35,531
42,445
22,129
31,183
47,593
52,906
68,312
203,803
284,570
362,248
350,205
427,188
425,196
496,037
549,553
579,054
586,833
633,934
1,240,156
1,356,798
1,269,876
1,731,514
1,817,417
1,917,341
1,929,261
2,402,962
2,135,888
2,075,663
2,070,842
1,995,935
1,799,469
1,930,177
1,761,645
2,267,948
2,267,9481,761,6451,930,1771,799,4691,995,9352,070,8422,075,6632,135,8882,402,9621,929,2611,917,3411,817,4171,731,5141,269,8761,356,7981,240,156633,934586,833579,054549,553496,037425,196427,188350,205362,248284,570203,80368,31252,90647,59331,18322,12942,44535,53127,05227,853
   > Total Current Liabilities 
13,371
26,114
28,317
35,172
15,826
20,465
29,316
35,058
49,985
49,952
103,161
149,988
141,896
186,435
188,424
246,452
238,809
271,679
265,734
310,312
451,797
551,195
645,721
1,075,199
1,112,542
1,242,314
1,304,435
1,599,555
1,376,306
1,398,409
1,411,311
1,468,528
1,254,551
1,405,109
1,283,297
1,810,113
1,810,1131,283,2971,405,1091,254,5511,468,5281,411,3111,398,4091,376,3061,599,5551,304,4351,242,3141,112,5421,075,199645,721551,195451,797310,312265,734271,679238,809246,452188,424186,435141,896149,988103,16149,95249,98535,05829,31620,46515,82635,17228,31726,11413,371
       Short-term Debt 
30,497
101,509
93,894
82,617
38,720
168,535
118,086
280,660
229,726
146,424
548,925
597,914
973,381
931,208
1,390,276
1,068,509
849,167
618,803
375,768
364,728
1,417,097
1,807,744
3,254,300
335,015
0
0
0
0
0
0
0
0
0
0
0
0
000000000000335,0153,254,3001,807,7441,417,097364,728375,768618,803849,1671,068,5091,390,276931,208973,381597,914548,925146,424229,726280,660118,086168,53538,72082,61793,894101,50930,497
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,940
8,740
700
0
11,298
26,061
50,222
335,015
405,045
434,802
442,372
427,565
407,387
380,729
441,275
328,969
281,808
421,052
328,561
688,366
688,366328,561421,052281,808328,969441,275380,729407,387427,565442,372434,802405,045335,01550,22226,06111,29807008,7408,9400000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
105,320
148,536
112,282
122,488
98,364
157,173
146,265
231,957
146,923
168,826
206,203
262,400
236,915
234,355
252,071
294,781
241,360
266,975
341,857
315,111
315,111341,857266,975241,360294,781252,071234,355236,915262,400206,203168,826146,923231,957146,265157,17398,364122,488112,282148,536105,3200000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,746
56,862
106,001
64,561
69,238
104,583
182,095
186,607
188,098
353,337
302,857
257,851
228,174
340,642
69,510
318,640
63,651
68,004
68,00463,651318,64069,510340,642228,174257,851302,857353,337188,098186,607182,095104,58369,23864,561106,00156,86236,746000000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
310,744
307,375
321,099
323,622
788,359
805,603
624,155
656,315
704,875
675,027
624,826
803,407
759,582
677,254
659,531
527,407
544,918
525,068
478,348
457,835
457,835478,348525,068544,918527,407659,531677,254759,582803,407624,826675,027704,875656,315624,155805,603788,359323,622321,099307,375310,7440000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
232,654
238,810
254,991
240,695
239,191
291,655
151,551
183,637
193,017
194,856
200,906
202,113
201,605
185,207
208,058
209,148
206,298
207,426
0
0
00207,426206,298209,148208,058185,207201,605202,113200,906194,856193,017183,637151,551291,655239,191240,695254,991238,810232,6540000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49,903
47,261
57,094
516,201
482,783
443,925
443,261
485,293
445,999
386,307
558,253
517,988
450,126
414,569
283,742
0
291,821
0
0
00291,8210283,742414,569450,126517,988558,253386,307445,999485,293443,261443,925482,783516,20157,09447,26149,90300000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160,679
0
0
0
0
0
00000160,679000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,608,769
1,553,877
1,278,478
962,205
2,812,214
2,536,298
4,287,494
3,869,243
4,003,587
3,606,775
3,357,073
6,242,987
5,885,500
5,302,544
4,655,171
4,383,355
4,157,306
3,798,559
3,763,234
3,537,327
3,537,3273,763,2343,798,5594,157,3064,383,3554,655,1715,302,5445,885,5006,242,9873,357,0733,606,7754,003,5873,869,2434,287,4942,536,2982,812,214962,2051,278,4781,553,8771,608,7690000000000000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
78
78
78
79
101
102
118
118
119
120
121
133
133
134
135
135
136
137
0
0
00137136135135134133133121120119118118102101797878780000000000000000
   Retained Earnings Total Equity000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000-73,354-61,443-51,157-43,375-36,709-28,938-26,159-23,267-19,722-18,792-17,236-16,127-13,627-12,535-9,073-8,392-7,473-7,327-6,845-6,557-6,084-5,785-5,532-4,837
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,777,474
2,814,449
2,861,012
2,925,970
5,138,239
5,200,275
7,367,799
7,414,932
7,486,518
7,561,155
7,724,822
11,191,007
11,268,290
11,356,686
11,451,566
11,540,979
11,644,957
11,752,019
0
0
0011,752,01911,644,95711,540,97911,451,56611,356,68611,268,29011,191,0077,724,8227,561,1557,486,5187,414,9327,367,7995,200,2755,138,2392,925,9702,861,0122,814,4492,777,4740000000000000000
   Treasury Stock000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,649
-3,549
-16,894
-8,001
-6,548
-9,299
-419
6,942
3,204
12,095
12,580
17,950
17,454
-82,450
-161,523
-77,417
-55,059
-143,687
0
0
00-143,687-55,059-77,417-161,523-82,45017,45417,95012,58012,0953,2046,942-419-9,299-6,548-8,001-16,894-3,5493,6490000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,458,779
Cost of Revenue-379,920
Gross Profit2,078,8592,078,859
 
Operating Income (+$)
Gross Profit2,078,859
Operating Expense-3,666,515
Operating Income-1,207,736-1,587,656
 
Operating Expense (+$)
Research Development1,778,594
Selling General Administrative1,504,501
Selling And Marketing Expenses-
Operating Expense3,666,5153,283,095
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-74,009
Net Interest Income74,009
 
Pretax Income (+$)
Operating Income-1,207,736
Net Interest Income74,009
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-825,836-1,515,627
EBIT - interestExpense = 0
-881,708
-881,708
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--825,836
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-825,836
Tax Provision-55,872
Net Income From Continuing Ops-881,708-881,708
Net Income-881,708
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net307,891-74,009
 

Technical Analysis of Beigene
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Beigene. The general trend of Beigene is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Beigene's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Beigene Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 82.65 < 83.00 < 94.30.

The bearish price targets are: 75.30 > 74.90 > 73.80.

Tweet this
Beigene Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Beigene Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Beigene Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Beigene Ltd. The current macd is -4.11226744.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Beigene price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Beigene. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Beigene price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Beigene Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBeigene Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Beigene Ltd. The current adx is 18.71.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Beigene shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Beigene Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Beigene Ltd. The current sar is 90.10.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Beigene Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Beigene Ltd. The current rsi is 28.05. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Beigene Ltd Daily Relative Strength Index (RSI) ChartBeigene Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Beigene Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Beigene price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Beigene Ltd Daily Stochastic Oscillator ChartBeigene Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Beigene Ltd. The current cci is -168.48931012.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Beigene Ltd Daily Commodity Channel Index (CCI) ChartBeigene Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Beigene Ltd. The current cmo is -58.82503407.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Beigene Ltd Daily Chande Momentum Oscillator (CMO) ChartBeigene Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Beigene Ltd. The current willr is -97.15909091.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Beigene Ltd Daily Williams %R ChartBeigene Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Beigene Ltd.

Beigene Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Beigene Ltd. The current atr is 3.50887976.

Beigene Ltd Daily Average True Range (ATR) ChartBeigene Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Beigene Ltd. The current obv is 10,051,379.

Beigene Ltd Daily On-Balance Volume (OBV) ChartBeigene Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Beigene Ltd. The current mfi is 23.58.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Beigene Ltd Daily Money Flow Index (MFI) ChartBeigene Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Beigene Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Beigene Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Beigene Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.051
Ma 20Greater thanMa 5091.175
Ma 50Greater thanMa 10093.477
Ma 100Greater thanMa 20099.106
OpenGreater thanClose79.950
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Beigene with someone you think should read this too:
  • Are you bullish or bearish on Beigene? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Beigene? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Beigene Ltd

I send you an email if I find something interesting about Beigene Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Beigene Ltd.

Receive notifications about Beigene Ltd in your mailbox!